Neuronal excitability and pace-making in the sinoatrial node are controlled by low-voltage activated Ca V 1.3 Ltype Ca 2+ channels. We recently found that in related Ca V 1.4 channels a highly-structured distal C-terminal motif (CTM) modulates voltage-and Ca 2+ -dependent gating (CDI). In Ca V 1.3, C-terminal splicing leads to a fulllength (Ca V 1.3L) and at least 1 short (Ca V 1.3S) splice form. If a CTM would also modulate Ca V 1.3 gating it would be present in Ca V 1.3L but not Ca V 1.3S variants. We therefore compared the biophysical properties of Ca V 1.3L or Ca V 1.3S coexpressed with β3 + α2δ-1 in tsA-201 cells using the whole-cell patch-clamp technique. Ca V 1.3S channels activated at more negative potentials compared to Ca V 1.3L (~ -10 mV, p < 0.0001), inactivated faster (p < 0.01) and showed more CDI (p < 0.01). These changes resulted in a decreased window current shifted to more hyperpolarized potentials likely to cause a reduction in the channels' dynamic range. Removal of the C-terminal 158 (Ca V 1.3 Δ1158 ) or 76 amino acids was sufficient to induce gating properties similar to Ca V 1.3S. FRET experiments revealed interaction of the last 158 amino acids (C 158 ) to a proximal C-terminal domain in Ca V 1.3L. Coexpression of C 158 with Ca V 1.3 Δ1158 completely restored Ca V 1.3L gating properties confirming this protein interaction. Thus Ca V 1.3 channel gating is under control of the distal C-terminus allowing alternative splicing to finetune channel activity and adapt channel function to physiological needs.
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